Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-06-23

Clinical Trial Update: DNA Single Nucleotide Polymorphisms as Predictors of Toxicity

View source ↗

Summary

The document describes an ongoing clinical trial investigating whether DNA single nucleotide polymorphisms can predict treatment toxicity in ovarian cancer and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: OvaGene Oncology, Inc. | Conditions: Ovarian Neoplasms, Fallopian Tube Neoplasms | Status: UNKNOWN